Company profile
Becton, Dickinson and Company
NYSE: BDX · Healthcare · Medical - Instruments & Supplies
#25 of 1,422 Healthcare companies by revenue54th-percentile growth
EA Score
83B+FH 86DQ 86GM 63SS 99
v0.1 · 65/100 weight · provisional
↑ listing tenure, market scale · ↓ 3-yr revenue growth, revenue growth (YoY)
Methodology →Revenue TTM
$21.4B
Rev growth YoY (TTM)
+2.4%
Net income (FY)
$1.7B
Employees
72,000
as of 2026-08-04
Market cap
$61.7B
as of 2026-08-04
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$21.8B$21.8B2025
Net income$1.7B$1.7B2025
Operating income$2.6B$2.6B2025
Total assets$55.3B$55.3B2025
Equity$25.4B$25.4B2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Medical52%
Interventional24%
Life Sciences24%
By geography
UNITED STATES59%
Europe22%
Asia14%
Others Country6%
The read
What is Becton, Dickinson and Company’s revenue?
Becton, Dickinson and Company booked $21.8B in FY2025 revenue, growing 8.2% year over year — about the middle of the pack among Healthcare companies we track, at a 7.7% net margin.
Peers · Healthcare
Medline Inc.62CStryker Corporation87ADanaher Corporation87ATenet Healthcare Corporation78B+GE HealthCare Technologies Inc.69BBoston Scientific Corporation88ANeighbors
Bergen →Key facts
CEOThomas E. Polen Jr.
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersFranklin Lakes, NJ
ExchangeNYSE: BDX
Employees72,000
IPO date1973-02-21
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.